Lista de

breast carcinoma
18
"Classical and non-classical thyroid hormone intracellular pathways involved in T lymphoma growth" (2015) Arcos, M.L.B.;Sterle, H.;Cayrol, F. (...)Cremaschi, G.A. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry. 15(1):37-42
"Hsp90-binding immunophilins as a potential new platform for drug treatment" (2013) Erlejman, A.G.; Lagadari, M.; Galigniana, M.D. Future Medicinal Chemistry. 5(5):591-607
"The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins " (2012) Lanari, C.;Giulianelli, S.;Vaqué, J.P. (...)Gutkind, J.S. Medicina (Argentina). 72(4):315-320
"Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer" (2012) Schillaci, R.;Guzmán, P.;Cayrol, F. (...)Elizalde, P.V. BMC Cancer. 12
"Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein" (2012) Goddio, M.V.;Gattelli, A.;Slomiansky, V. (...)Kordon, E.C. Breast Cancer Research and Treatment. 135(3):749-758
"Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects" (2011) Bottino, M.C.;Cerliani, J.P.;Rojas, P. (...)Lanari, C. Breast Cancer Research and Treatment. 126(3):621-636
"Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas" (2009) Wargon, V.;Helguero, L.A.;Bolado, J. (...)Lanari, C. Breast Cancer Research and Treatment. 116(3):449-460
"Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis" (2008) Giulianelli, S.;Cerliani, J.P.;Lamb, C.A. (...)Lanari, C. International Journal of Cancer. 123(11):2518-2531
"Multiple sites of tumorigenesis in transgenic mice overproducing hCG" (2005) Huhtaniemi, I.; Rulli, S.; Ahtiainen, P.; Poutanen, M. Molecular and Cellular Endocrinology. 234(1-2):117-126
"Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients" (2002) De Cavanagh, E.M.V.;Honegger, A.E.;Hofer, E. (...)Fraga, C. Cancer. 94(12):3247-3251
"Influence of mast cells on two murine mammary adenocarcinomas" (1996) De Cidre, L.L.;Eijan, A.M.;Bertolesi, G. (...)De Lustig, E.S. Tumor Biology. 17(6):345-353
"Correlation of TGF-(si expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas" (1995) Elizalde, P.V.;Guerra, F.K.;Gravano, M. (...)Lupu, R. Cancer Investigation. 13(2):173-180
"Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins" (1994) Bertolesi, G.E.; De Cidre, L.L.; Eiján, A.M. Tumor Biology. 15(5):275-283
"Binding of estradiol receptor complexes to isolated human breast chromatin" (1977) Charreau, E.H.; Baldi, A. Molecular and Cellular Biochemistry. 16(2-3):79-86